On 25.09.2015 Verkhovna Rada of Ukraine registered the Draft Law on Amendments Introduction to Article 15 of the Law of Ukraine "On Medicinal Products". This draft law provides for brining into compliance with the Law of Ukraine «On Main Principles of State Monitoring (Control) of Economic Activity» the authorities of State Administration on Medicinal Products officials, in particular the draft law designates that the production (manufacturing) and distribution of medicinal products may be suspended only by the court decision.
It is worth to mention that currently the relevant decisions are made by State Administration on Medicinal Products which is in direct contradiction to part 5, article 4 of the abovementioned Law with regard to which the production (manufacturing) and distribution of products by business entities may be suspended exclusively by court decision.
An undeniable advantage of the draft law adoption shall be the mutual harmonization of acting Laws of Ukraine «On Medicinal Products» and «On Main Principles of State Monitoring (Control) of Economic Activity».
Moreover, with this draft law adoption it is expected that the regulatory burden on business entities will be eased.
At the same time, please note that in case of suspension of production and distribution of medicinal products through the court proceeding there is a risk of increase of disposition and decision making time.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
